Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 9/20 | 0.36 |
| ▸ | RARA | P10276 | 2/20 | 0.35 |
| ▸ | RARG | P13631 | 1/20 | 0.35 |
| ▸ | DHODH | Q02127 | 1/20 | 0.35 |
| ▸ | CTSV | O60911 | 1/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ASAH1 | Q13510 | 2/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3027348 | 0.86 | HRH3 (0.36) | RARBCTSVCTSLHSD11B1ALDH1A1 | |
| SCHEMBL3031793 | 0.85 | HRH3 (0.38) | RARBCTSVCTSLHSD11B1ALDH1A1 | |
| SCHEMBL13694878 | 0.85 | S1PR1 (0.36) | RARBCTSVCTSLHSD11B1ALDH1A1 | |
| SCHEMBL13219237 | 0.82 | HRH3 (0.33) | RARBRARAHSD11B1MEN1ALDH1A1 | |
| SCHEMBL13219241 | 0.80 | HRH3 (0.33) | RARB | |
| SCHEMBL3037388 | 0.78 | PTGDR (0.38) | MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL7270823 | 0.76 | GPR84 (0.37) | — | |
| SCHEMBL19512280 | 0.76 | RARB (0.46) | RARBRARARARGDHODHMEN1 | |
| SCHEMBL3036691 | 0.73 | THRA (0.37) | KMT2A | |
| SCHEMBL9914999 | 0.73 | RARB (0.39) | RARBRARARARGDHODHMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9249136-B2 | 3H-naphtho [2,1-B] pyrans as photochromic dichroic dyes and optical article containing them | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2016-02-02 | — | — | US | disclosed |
| US-9249136-B2 | 3H-naphtho [2,1-B] pyrans as photochromic dichroic dyes and optical article containing them | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2016-02-02 | — | — | US | disclosed |
| EP-2066650-B1 | 3H-NAPHTHO[2,1-B]PYRANS AS PHOTOCHROMIC DICHROIC DYES AND OPTICAL ARTICLE CONTAINING THEM | ESSILOR INT (FR) | 2011-12-21 | — | — | EP | disclosed |
| US-20100202033-A1 | 3H-NAPHTH0 [2,1-B] PYRANS AS PHOTOCHROMIC DICHROIC DYES AND OPTICAL ARTICLE CONTAINING THEM | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D' OPTIQUE) (FR) | 2010-08-12 | — | — | US | disclosed |
| US-20100202033-A1 | 3H-NAPHTH0 [2,1-B] PYRANS AS PHOTOCHROMIC DICHROIC DYES AND OPTICAL ARTICLE CONTAINING THEM | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D' OPTIQUE) (FR) | 2010-08-12 | — | — | US | disclosed |
| EP-2066650-A1 | 3H-NAPHTH0 [2, 1-B]PYRANS AS PHOTOCHROMIC DICHROIC DYES AND OPTICAL ARTICLE CONTAINING THEM | ESSILOR INTERNATIONAL (Compagnie Générale d'Optique) (FR) | 2009-06-10 | — | — | EP | disclosed |
| WO-2008030226-A1 | 3H-NAPHTH0 [2, 1-B] PYRANS AS PHOTOCHROMIC DICHROIC DYES AND OPTICAL ARTICLE CONTAINING THEM | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2008-03-13 | — | — | WO | disclosed |
| WO-2008030226-A1 | 3H-NAPHTH0 [2, 1-B] PYRANS AS PHOTOCHROMIC DICHROIC DYES AND OPTICAL ARTICLE CONTAINING THEM | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2008-03-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100202033-A1 | 3H-NAPHTH0 [2,1-B] PYRANS AS PHOTOCHROMIC DICHROIC DYES AND OPTICAL ARTICLE CONTAINING THEM | NR0B1, NR0B2, NR4A1 | RARB 9/4885RARA 4/4885RARG 42/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.